Skip to main content
EXACT Therapeutics AS logo

EXACT Therapeutics AS — Investor Relations & Filings

Ticker · EXTX ISIN · NO0010852213 LEI · 2138006ZE5JAL39AGD55 OL Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2022-06-08 AGM Information
Country NO Norway
Listing OL EXTX

About EXACT Therapeutics AS

https://www.exact-tx.com/

EXACT Therapeutics AS is a clinical-stage biopharmaceutical company developing its proprietary technology platform, Acoustic Cluster Therapy (ACT®), for targeted therapeutic enhancement. The ACT® platform uses ultrasound to amplify the effect of co-administered drugs, with a primary focus on oncology. Its biomechanical mode of action increases the local uptake of therapeutics from blood vessels into the surrounding tissue, including across the blood-brain barrier, without requiring drug reformulation. This non-invasive technology is designed to be compatible with standard ultrasound systems. The company's pipeline includes the ENACT study, a Phase 2 trial evaluating ACT® in patients with locally advanced pancreatic cancer, following the completion of the ACTIVATE Phase 1 study in patients with liver metastases.

Recent filings

Filing Released Lang Actions
EXACT Therapeutics AS: Minutes of Annual General Meeting 2022
AGM Information Classification · 99% confidence The document explicitly states it contains the "Minutes of Annual General Meeting 2022" for EXACT Therapeutics AS. It details the date of the AGM (June 8th, 2022), the attendance percentage (26%), and confirms that all resolutions were approved. This content directly relates to the proceedings and outcomes of the Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document is short and serves as an announcement/record of the meeting minutes, fitting the AGM-R definition better than a general Regulatory Filing (RNS).
2022-06-08 English
EXACT Therapeutics AS to present at the Annual International Symposium for Therapeutic Ultrasound (ISTU) Conference in Toronto
Regulatory Filings Classification · 96% confidence The document is a press release announcing that EXACT Therapeutics AS will be presenting preclinical results at the Annual International Symposium for Therapeutic Ultrasound (ISTU) Conference. It details the topic, session, date, and time of the presentation. This type of announcement, which informs stakeholders about participation in an external scientific or industry event, does not fit the definitions for formal regulatory filings (10-K, IR, ER, etc.) or specific corporate actions (DIV, CAP, DIRS). It is an announcement related to investor/scientific engagement, but the closest fit among the provided options, given its nature as a brief, informational update about company activity and presentation schedule, is often categorized under general Regulatory Filings (RNS) if a more specific category like Investor Presentation (IP) or AGM-R is not applicable. Since this is an announcement about presenting *at* a conference, not the presentation itself, and it's not a standard financial report, RNS serves as the most appropriate general regulatory/corporate announcement fallback.
2022-06-01 English
EXACT Therapeutics AS to present at the Annual International Symposium for Therapeutic Ultrasound (ISTU) Conference in Toronto
Regulatory Filings Classification · 95% confidence The document is a short press release from EXACT Therapeutics AS announcing that they will be presenting preclinical results at the Annual International Symposium for Therapeutic Ultrasound (ISTU) Conference. It details the topic, session, date, and time of the presentation. Since this is an announcement about participation in a scientific conference, and not a formal regulatory filing like a 10-K, an Earnings Release (ER), or a comprehensive Interim Report (IR), it best fits the category for general corporate news or announcements that don't fit elsewhere. Given the options, it is a general corporate announcement. It is not an AGM-R (which is material *from* the AGM), nor is it a Call Transcript (CT) or Investor Presentation (IP). It is most closely related to general corporate updates, but since it is an announcement of participation in an external scientific event, and not a core financial report, the most appropriate general category is Regulatory Filings (RNS) as a catch-all for non-standard announcements, or potentially a very broad interpretation of Investor Presentation (IP) if the presentation itself was attached, but here it is just an announcement *about* a presentation. Given the context of presenting scientific data at a symposium, it is a form of investor/scientific communication. However, since it is purely an announcement of a presentation at an external scientific symposium, and not a formal company presentation (IP) or a core financial report, it falls under general corporate news. RNS is the fallback for miscellaneous regulatory/corporate announcements. I will classify it as RNS as it is a general corporate update/announcement.
2022-06-01 English
EXACT Therapeutics AS - Notice of Annual General Meeting 2022
AGM Information Classification · 100% confidence The document is titled "INNKALLING TIL ORDINÆR GENERALFORSAMLING" (Notice of Annual General Meeting) in Norwegian and "NOTICE OF ANNUAL GENERAL MEETING" in English. It explicitly details the agenda for a general meeting scheduled for June 8, 2022, including items like the approval of the annual accounts, election of board members, and authorization for capital increases. This content is characteristic of a formal notice sent to shareholders regarding an upcoming Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2022-05-30 English
EXACT Therapeutics AS - Notice of Annual General Meeting 2022
Annual Report Classification · 100% confidence The document is explicitly titled 'Annual Report 2021' and contains comprehensive sections including a Chair's Statement, Operational and Clinical Review, Financial Review, Corporate Governance, and Financial Statements. It is a full-length annual report, not an announcement or a summary, and therefore fits the definition of a 10-K (Annual Report). FY 2021
2022-05-30 English
EXACT Therapeutics AS - Notice of Annual General Meeting 2022
AGM Information Classification · 98% confidence The document explicitly states it is a 'Notice of Annual General Meeting 2022' for EXACT Therapeutics AS. It provides the date, time, and location (virtual) for the AGM and mentions that the notice, attendance/proxy forms, proposed resolutions, and the 2021 Annual Report are attached or available online. Since this document is the official notice calling for the meeting and providing necessary administrative details, it falls under the category for AGM materials. The most specific code is AGM-R (AGM Information). Although it mentions the 2021 Annual Report is attached, the primary purpose of this specific text is the AGM notice itself.
2022-05-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.